Determination of deamidation artifacts introduced by sample preparation using 18O-labeling and tandem mass spectrometry analysis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Analytical Chemistry

• Publication date

  2012-07-17

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/ac3013362PMID 22881398
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein isoaspartate methyltransferase-mediated 18O-labeling of isoaspartic acid for mass spectrometry analysis.

  2012cited by this paper
• Probing deamidation in therapeutic immunoglobulin gamma (IgG1) by 'bottom-up' mass spectrometry with electron transfer dissociation.

  2010cited by this paper
• Safety of therapeutic monoclonal antibodies.

  2010cited by this paper
• Analysis of isoaspartic Acid by selective proteolysis with Asp-N and electron transfer dissociation mass spectrometry.

  2010cited by this paper
• 18O2-labeling in quantitative proteomic strategies: a status report.

  2009cited by this paper
• An improved trypsin digestion method minimizes digestion-induced modifications on proteins.

  2009cited by this paper
• Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody.

  2009cited by this paper
• Human antibody Fc deamidation in vivo.

  2009cited by this paper
• Effect of protein structure on deamidation rate in the Fc fragment of an IgG1 monoclonal antibody

  2009cited by this paper
• Chemo-enzymatic detection of protein isoaspartate using protein isoaspartate methyltransferase and hydrazine trapping.

  2008cited by this paper
• Isomerization of a single aspartyl residue of anti-epidermal growth factor receptor immunoglobulin gamma2 antibody highlights the role avidity plays in antibody activity.

  2008cited by this paper
• Method to differentiate asn deamidation that occurred prior to and during sample preparation of a monoclonal antibody.

  2008cited by this paper
• Use of 18O labels to monitor deamidation during protein and peptide sample processing

  2008cited by this paper
• Proteolytic 18O-labeling strategies for quantitative proteomics.

  2007cited by this paper
• A modified peptide mapping strategy for quantifying site-specific deamidation by electrospray time-of-flight mass spectrometry.

  2007cited by this paper
• Identification of deamidation and isomerization sites on pharmaceutical recombinant antibody using H(2)(18)O.

  2007cited by this paper
• pH dependency of the carboxyl oxygen exchange reaction catalyzed by lysyl endopeptidase and trypsin.

  2006cited by this paper
• Analysis of recombinant monoclonal antibody isoforms by electrospray ionization mass spectrometry as a strategy for streamlining characterization of recombinant monoclonal antibody charge heterogeneity.

  2006cited by this paper
• Influence of pH, buffer species, and storage temperature on physicochemical stability of a humanized monoclonal antibody LA298.

  2006cited by this paper
• Deamidation of -Asn-Gly- sequences during sample preparation for proteomics: Consequences for MALDI and HPLC-MALDI analysis.

  2006cited by this paper
• Structural Characterization of a Recombinant Monoclonal Antibody by Electrospray Time-of-Flight Mass Spectrometry

  2005cited by this paper
• Asparagine Deamidation Perturbs Antigen Presentation on Class II Major Histocompatibility Complex Molecules*

  2005cited by this paper
• Identification and characterization of deamidation sites in the conserved regions of human immunoglobulin gamma antibodies.

  2005cited by this paper
• In vivo deamidation characterization of monoclonal antibody by LC/MS/MS.

  2005cited by this paper
• Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies

  2004cited by this paper
• Analysis of isoaspartate in a recombinant monoclonal antibody and its charge isoforms.

  2003cited by this paper
• Identification of multiple sources of charge heterogeneity in a recombinant antibody.

  2001cited by this paper
• Determination of the Origin of Charge Heterogeneity in a Murine Monoclonal Antibody

  2000cited by this paper
• Isoaspartyl Post-translational Modification Triggers Autoimmune Responses to Self-proteins*

  1999cited by this paper
• Protease‐catalyzed incorporation of 18O into peptide fragments and its application for protein sequencing by electrospray and matrix‐assisted laser desorption/ionization mass spectrometry

  1996cited by this paper
• Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity.

  1996cited by this paper
• Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation.

  1987cited by this paper

• Local neighbor Normalization: Reconciling accurate normalization and heterogeneity recovery in large-scale metabolomics.

  2025cites this paper
• Revisiting the Effect of Trypsin Digestion Buffers on Artificial Deamidation.

  2025cites this paper
• Multiepitope recognition technology promotes the in-depth analysis of antibody‒drug conjugates

  2024cites this paper
• Direct deamidation analysis of intact adeno-associated virus serotype 9 capsid proteins using reversed-phase liquid chromatography.

  2023cites this paper
• Testing the link between isoaspartate and Alzheimer’s disease etiology

  2022cites this paper
• The Acyl-Proteome of Syntrophus aciditrophicus Reveals Metabolic Relationships in Benzoate Degradation

  2022cites this paper
• Restoring the biological activity of crizanlizumab at physiological conditions through a pH-dependent aspartic acid isomerization reaction

  2022cites this paper
• Mass spectrometric studies of the variety of beta-amyloid proteoforms in Alzheimer's disease.

  2022cites this paper
• Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors

  2022cites this paper
• An Improved Isotope Labelling Method for Quantifying Deamidated Cobratide Using High-Resolution Quadrupole-Orbitrap Mass Spectrometry

  2022cites this paper
• Uncovering the modified immunopeptidome reveals insights into principles of PTM-driven antigenicity

  2021cites this paper
• Therapeutic Fc-fusion proteins: Current analytical strategies.

  2020cites this paper
• Mass Spectrometry‐Based Strategies for Therapeutic Antibodies Extensive Characterization and Optimization (OptimAbs)

  2020cites this paper
• An O18-Labeling Assisted LC-MS Method for Accurate Quantitation of Unprocessed C-terminal Lysine in Therapeutic Monoclonal Antibodies.

  2020cites this paper
• From proof of concept to the routine use of an automated and robust multi-dimensional liquid chromatography mass spectrometry workflow applied for the charge variant characterization of therapeutic antibodies.

  2019cites this paper
• Deamidation of Amino Acids on the Surface of Adeno-Associated Virus Capsids Leads to Charge Heterogeneity and Altered Vector Function.

  2018cites this paper
• Strategies for analysis of isomeric peptides.

  2018cites this paper
• Microheterogeneity of Recombinant Antibodies: Analytics and Functional Impact

  2018cites this paper
• Identification and quantification of product-related quality attributes in bio-therapeutic monoclonal antibody via a simple, and robust cation-exchange HPLC method compatible with direct online detection of UV and native ESI-QTOF-MS analysis.

  2018cites this paper
• Deamidation Slows Curli Amyloid-Protein Aggregation.

  2017cites this paper
• Infrared spectroscopic characterization of monocytic microvesicles (microparticles) released upon lipopolysaccharide stimulation

  2017cites this paper
• A Generic HPLC Method for Absolute Quantification of Oxidation in Monoclonal Antibodies and Fc-Fusion Proteins Using UV and MS Detection.

  2017cites this paper
• Structural Characterization of Cross-Linked Species in Trastuzumab Emtansine (Kadcyla).

  2016cites this paper
• A conventional procedure to reduce Asn deamidation artifacts during trypsin peptide mapping.

  2016cites this paper
• Protein deamidation in biopharmaceutical manufacture: understanding, control and impact

  2016cites this paper
• Massenspektrometrische Charakterisierung von Proteinen aus Kondensaten der Pikosekunden-Infrarot-Laserablation

  2016cites this paper
• Mass Spectrometry and Protein Analysis: Structure, Oligomerization and Interaction

  2016cites this paper
• CE‐MS for the analysis of intact proteins

  2016cites this paper
• High Resolution CZE-MS Quantitative Characterization of Intact Biopharmaceutical Proteins: Proteoforms of Interferon-β1.

  2016cites this paper
• Sample normalization methods in quantitative metabolomics.

  2016cites this paper
• Mildly acidic conditions eliminate deamidation artifact during proteolysis: digestion with endoprotease Glu-C at pH 4.5

  2016cites this paper
• Full validation of therapeutic antibody sequences by middle-up mass measurements and middle-down protein sequencing

  2016cites this paper
• Sequence comparison, molecular modeling, and network analysis predict structural diversity in cysteine proteases from the Cape sundew, Drosera capensis

  2016cites this paper
• Site-specific characterization and absolute quantification of pegfilgrastim oxidation by top-down high-performance liquid chromatography-mass spectrometry.

  2015cites this paper
• Fast filtration sampling protocol for mammalian suspension cells tailored for phosphometabolome profiling by capillary ion chromatography - tandem mass spectrometry.

  2015cites this paper
• Advances in mass spectrometry driven O-glycoproteomics.

  2015cites this paper
• Quantification of biopharmaceuticals and biomarkers in complex biological matrices: a comparison of liquid chromatography coupled to tandem mass spectrometry and ligand binding assays

  2015cites this paper
• Detection and quantitation of succinimide in intact protein via hydrazine trapping and chemical derivatization.

  2014cites this paper
• The exo-proteome and exo-metabolome of Nostoc punctiforme (Cyanobacteria) in the presence and absence of nitrate

  2014cites this paper
• Development of methods for the analysis of protein post-translational modific ations: isoaspartic acid and protein crosslinking

  2014cites this paper
• Modern chromatographic and mass spectrometric techniques for protein biopharmaceutical characterization.

  2014cites this paper
• Methylglyoxal in cells elicits a negative feedback loop entailing transglutaminase 2 and glyoxalase 1

  2014cites this paper
• Quantitation of asparagine deamidation by isotope labeling and liquid chromatography coupled with mass spectrometry analysis.

  2013cites this paper
• Large Scale Chemical Cross-linking Mass Spectrometry Perspectives

  2013cites this paper
• Measurement of DNA concentration as a normalization strategy for metabolomic data from adherent cell lines.

  2013cites this paper
• Comprehensive characterization of protein structures by liquid chromatography coupled with mass spectrometry (LC-MS)

  2013cites this paper
• Deamidation of asparagine to aspartate destabilizes Cu, Zn superoxide dismutase, accelerates fibrillization, and mirrors ALS-linked mutations.

  2013cites this paper
• Integrated proteomic analysis of major isoaspartyl-containing proteins in the urine of wild type and protein L-isoaspartate O-methyltransferase-deficient mice.

  2013cites this paper
• Brain proteomics supports the role of glutamate metabolism and suggests other metabolic alterations in protein l-isoaspartyl methyltransferase (PIMT)-knockout mice.

  2013cites this paper